Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: Behavioral treatment+naltrexone compared to usual care

David Otiashvili, Irma Kirtadze, Kevin E. O'Grady, Hendrée E. Jones

Research output: Contribution to journalArticle

Abstract

Background: To test the initial feasibility of a novel 22-week comprehensive intervention pairing behavioral treatment with naltrexone that aimed at engaging, retaining, and treating opioid-injecting men in the Republic of Georgia. Methods: Forty opioid-injecting male and their drug-free female partners participated in a two-group randomized clinical trial at the field site of the Union Alternative Georgia, in Tbilisi, Republic of Georgia. The comprehensive intervention that paired behavioral treatment with naltrexone for the male participants (n = 20) included counseling sessions using Motivational Interviewing for both the male participant and the couple, monetary incentives for drug abstinence, and research-supported detoxification followed by naltrexone treatment. Male participants in the usual care condition (n = 20) had the opportunity to attend once-a-week individualized education sessions and upon request receive referrals to detoxification programs and aftercare that could or could not have included naltrexone. Outcome measures included entry into inpatient detoxification and naltrexone treatment, urine drug screening, reduction in illicit substance use, use of benzodiazepines, injection of buprenorphine, and needle and syringe sharing. Results: The comprehensive intervention condition showed significantly more weekly urine samples negative for illicit opioids during weeks 1-22 (7.0 vs. 1.4; p<.001) and reported significant declines in use of benzodiazepines and injection of buprenorphine (both ps <.004). Conclusions: The first behavioral treatment randomized clinical trial in the Republic of Georgia found that the use of tailored behavioral therapy paired with naltrexone is both feasible and efficacious for treating drug use and reducing HIV drug-risk behavior in Georgian men.

Original languageEnglish (US)
Pages (from-to)14-21
Number of pages8
JournalDrug and Alcohol Dependence
Volume120
Issue number1-3
DOIs
StatePublished - Jan 1 2012

Fingerprint

Georgia (Republic)
Naltrexone
Opioid Analgesics
HIV
Detoxification
Needle Sharing
Pharmaceutical Preparations
Buprenorphine
Benzodiazepines
Therapeutics
Randomized Controlled Trials
Urine
Motivational Interviewing
Drug therapy
Syringes
Aftercare
Preclinical Drug Evaluations
Injections
Risk-Taking
Needles

Keywords

  • Behavioral treatment
  • Injection drug use
  • Naltrexone
  • Opioid dependence
  • Republic of Georgia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia : Behavioral treatment+naltrexone compared to usual care. / Otiashvili, David; Kirtadze, Irma; O'Grady, Kevin E.; Jones, Hendrée E.

In: Drug and Alcohol Dependence, Vol. 120, No. 1-3, 01.01.2012, p. 14-21.

Research output: Contribution to journalArticle

Otiashvili, David ; Kirtadze, Irma ; O'Grady, Kevin E. ; Jones, Hendrée E. / Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia : Behavioral treatment+naltrexone compared to usual care. In: Drug and Alcohol Dependence. 2012 ; Vol. 120, No. 1-3. pp. 14-21.
@article{3e6d4598c0eb4b89a342014ee79987ec,
title = "Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: Behavioral treatment+naltrexone compared to usual care",
abstract = "Background: To test the initial feasibility of a novel 22-week comprehensive intervention pairing behavioral treatment with naltrexone that aimed at engaging, retaining, and treating opioid-injecting men in the Republic of Georgia. Methods: Forty opioid-injecting male and their drug-free female partners participated in a two-group randomized clinical trial at the field site of the Union Alternative Georgia, in Tbilisi, Republic of Georgia. The comprehensive intervention that paired behavioral treatment with naltrexone for the male participants (n = 20) included counseling sessions using Motivational Interviewing for both the male participant and the couple, monetary incentives for drug abstinence, and research-supported detoxification followed by naltrexone treatment. Male participants in the usual care condition (n = 20) had the opportunity to attend once-a-week individualized education sessions and upon request receive referrals to detoxification programs and aftercare that could or could not have included naltrexone. Outcome measures included entry into inpatient detoxification and naltrexone treatment, urine drug screening, reduction in illicit substance use, use of benzodiazepines, injection of buprenorphine, and needle and syringe sharing. Results: The comprehensive intervention condition showed significantly more weekly urine samples negative for illicit opioids during weeks 1-22 (7.0 vs. 1.4; p<.001) and reported significant declines in use of benzodiazepines and injection of buprenorphine (both ps <.004). Conclusions: The first behavioral treatment randomized clinical trial in the Republic of Georgia found that the use of tailored behavioral therapy paired with naltrexone is both feasible and efficacious for treating drug use and reducing HIV drug-risk behavior in Georgian men.",
keywords = "Behavioral treatment, Injection drug use, Naltrexone, Opioid dependence, Republic of Georgia",
author = "David Otiashvili and Irma Kirtadze and O'Grady, {Kevin E.} and Jones, {Hendr{\'e}e E.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.drugalcdep.2011.06.012",
language = "English (US)",
volume = "120",
pages = "14--21",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia

T2 - Behavioral treatment+naltrexone compared to usual care

AU - Otiashvili, David

AU - Kirtadze, Irma

AU - O'Grady, Kevin E.

AU - Jones, Hendrée E.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: To test the initial feasibility of a novel 22-week comprehensive intervention pairing behavioral treatment with naltrexone that aimed at engaging, retaining, and treating opioid-injecting men in the Republic of Georgia. Methods: Forty opioid-injecting male and their drug-free female partners participated in a two-group randomized clinical trial at the field site of the Union Alternative Georgia, in Tbilisi, Republic of Georgia. The comprehensive intervention that paired behavioral treatment with naltrexone for the male participants (n = 20) included counseling sessions using Motivational Interviewing for both the male participant and the couple, monetary incentives for drug abstinence, and research-supported detoxification followed by naltrexone treatment. Male participants in the usual care condition (n = 20) had the opportunity to attend once-a-week individualized education sessions and upon request receive referrals to detoxification programs and aftercare that could or could not have included naltrexone. Outcome measures included entry into inpatient detoxification and naltrexone treatment, urine drug screening, reduction in illicit substance use, use of benzodiazepines, injection of buprenorphine, and needle and syringe sharing. Results: The comprehensive intervention condition showed significantly more weekly urine samples negative for illicit opioids during weeks 1-22 (7.0 vs. 1.4; p<.001) and reported significant declines in use of benzodiazepines and injection of buprenorphine (both ps <.004). Conclusions: The first behavioral treatment randomized clinical trial in the Republic of Georgia found that the use of tailored behavioral therapy paired with naltrexone is both feasible and efficacious for treating drug use and reducing HIV drug-risk behavior in Georgian men.

AB - Background: To test the initial feasibility of a novel 22-week comprehensive intervention pairing behavioral treatment with naltrexone that aimed at engaging, retaining, and treating opioid-injecting men in the Republic of Georgia. Methods: Forty opioid-injecting male and their drug-free female partners participated in a two-group randomized clinical trial at the field site of the Union Alternative Georgia, in Tbilisi, Republic of Georgia. The comprehensive intervention that paired behavioral treatment with naltrexone for the male participants (n = 20) included counseling sessions using Motivational Interviewing for both the male participant and the couple, monetary incentives for drug abstinence, and research-supported detoxification followed by naltrexone treatment. Male participants in the usual care condition (n = 20) had the opportunity to attend once-a-week individualized education sessions and upon request receive referrals to detoxification programs and aftercare that could or could not have included naltrexone. Outcome measures included entry into inpatient detoxification and naltrexone treatment, urine drug screening, reduction in illicit substance use, use of benzodiazepines, injection of buprenorphine, and needle and syringe sharing. Results: The comprehensive intervention condition showed significantly more weekly urine samples negative for illicit opioids during weeks 1-22 (7.0 vs. 1.4; p<.001) and reported significant declines in use of benzodiazepines and injection of buprenorphine (both ps <.004). Conclusions: The first behavioral treatment randomized clinical trial in the Republic of Georgia found that the use of tailored behavioral therapy paired with naltrexone is both feasible and efficacious for treating drug use and reducing HIV drug-risk behavior in Georgian men.

KW - Behavioral treatment

KW - Injection drug use

KW - Naltrexone

KW - Opioid dependence

KW - Republic of Georgia

UR - http://www.scopus.com/inward/record.url?scp=84155167859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155167859&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2011.06.012

DO - 10.1016/j.drugalcdep.2011.06.012

M3 - Article

C2 - 21742445

AN - SCOPUS:84155167859

VL - 120

SP - 14

EP - 21

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-3

ER -